Innova Captab Limited IPO

Mainboard

Pharmaceuticals

Listed On: Dec 29, 2023 at ₹ 452.1(NSE)

₹ 14784 /33 Shares

Check Allotment

Price Summary

Last Closing

1,016.00 (126.79%)

52 Week High

1,059.00

52 Week Low

421.35

Last Update

22-Nov-2024 3:30 PM

Innova Captab Limited IPO Details

21 Dec, 2023

Open Date

26 Dec, 2023

Close Date

27 Dec, 2023

Allotment Date

29 Dec, 2023

Listing Date

Issue Price

₹426-448 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Kfin Technologies Limited

List Price

452.1(NSE)

Listing Date

2023-12-29

Market Lot

Retail : 33 Shares (₹14,784/-)
S-HNI : 462 Shares (₹2,06,976/-)
B-HNI : 2,244 Shares (₹10,05,312/-)

Lead Manager

ICICI Securities Limited
Jm Financial Limited

Issue Size

Total ₹570.00 Cr :
#Fresh Issue: 7,142,857 shares (aggregating up to ₹320.00 Cr)
#Offer for Sale: 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr)

Retail Portion

35% (Number of Retail Applications: 1,34,943 Approx),
(Number of S-HNI Applications : 1,377 Approx),
(Number of B-HNI Applications : 2,754 Approx)

Subscription

55.24 times

IPO Docs

DRHP RHP ANCHOR

Innova Captab Limited IPO Subscription Details

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	2,544,643	1,908,482 1,272,322 636,161	4,453,125	8,906,250
Day 1 - 21-12-23 05:00 PM	0.44 x	0.96 1.04 x 0.93 x	2.13 x	1.41 x
Day 2 - 22-12-23 05:00 PM	1.09 x	3.28 4.35 x 2.74 x	5.02 x	3.54 x
Day 3 - 26-12-23 05:00 PM	116.73 x	64.94 71.59 x 51.63 x	17.12 x	55.24 x

Total No. of Applications: 2,392,340 (Approx)

Innova Captab Limited Valuations

Earnings Per Share (EPS)

₹14.16/-

P/E Ratio

31.64

RoNW

24.58%

Net Asset Value (NAV) - As on 31.03.22

₹N/A

Innova Captab Limited Company Financials All values are in ₹ Cr.

	31-Mar-23	31-Mar-22	31-Mar-21
Assets	704.41	575.48	369.62
Revenue	935.58	803.41	412.03
Profit After Tax	67.95	63.95	34.50

About The Company

Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.

The company's product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines.

In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company's own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.

As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company's manufacturing facility is located in Buddi, Haryana.

The company's customer base includes Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley Pharmaceuticals Limited, Cachet Pharmaceuticals Limited, Eris Healthcare Private Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Oaknet Healthcare Private Limited, Zuventus Healthcare Limited, Ajanta Pharma Limited, Mankind Pharma Limited and Smart Laboratories Private Limited.

As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.

Innova Captab Limited - Promoter(s)

Pre Issue Share Holding: 66.85%

Post Issue Share Holding: 51.68%

Company Promoter(s)

Manoj Kumar Lohariwala
Vinay Kumar Lohariwala

Innova Captab Limited IPO - Issue Objectives

Repayment and / or prepayment in part or in full, of certain outstanding loans of the Company
Investment in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML
Funding the working capital requirements
General corporate purposes

Innova Captab Limited IPO - Anchor Investors

Innova Captab IPO Anchor investors pick Rs 171 crore worth shares.

Several institutional investors including Morgan Stanley, Copthall Mauritius Investment, ICICI Prudential Mutual Fund, Kotak Mahindra Trustee, Ashoka Whiteoak Emerging Markets Trust, SBI Life Insurance Company, Bandhan Mutual Fund, Canara Robeco Mutual Fund, Aditya Birla Sun Life Insurance Company, Invesco India, and Integrated Core Strategies invested in the company via anchor book.

Innova Captab Limited IPO - FAQs

Ans. Innova Captab Limited IPO is a Mainboard IPO. The issue is priced at ₹426-448 per equity share. The minimum order quantity is 33 Shares. The IPO opens on Dec 21, 2023, and closes on Dec 26, 2023. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Innova Captab Limited IPO opens on Dec 21, 2023 and closes on Dec 26, 2023.

Ans. The size of Innova Captab Limited IPO is Total ₹570.00 Cr : #Fresh Issue: 7,142,857 shares (aggregating up to ₹320.00 Cr) #Offer for Sale: 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr).

Ans. The IPO price band is set between ₹426-448 per equity share.

Ans. To apply for Innova Captab Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Innova Captab Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Innova Captab Limited IPO is Dec 27, 2023.

Ans. The Innova Captab Limited IPO will be listed on Dec 29, 2023.

Ans. Follow the steps to check the allotment status for Innova Captab Limited IPO here.